Sirius Therapeutics

Company Drug

Sirius Therapeutics Pursues First-in-Human Trial for SRSD107 in Australia

Fineline Cube Nov 10, 2023

Sino-US biotech Sirius Therapeutics has announced its pursuit of Investigational New Drug (IND) approval in...

Company Deals

Sirius Therapeutics Secures USD 60 Million in Series B Financing for siRNA Therapy Development

Fineline Cube Oct 18, 2023

Sirius Therapeutics, a Shanghai-based developer of siRNA therapies, has successfully raised USD 60 million in...

Policy / Regulatory

U.S. Tariffs on Pharmaceuticals and Their Impact on China’s Medical Industry

Company Drug

Sichuan Biokin Launches Phase III Trial for BL-B01D1 in Urothelial Carcinoma

Company Drug

AbbVie’s Rinvoq Approved in EU for Giant Cell Arteritis

Company Drug

Bristol-Myers Squibb’s Opdivo/Yervoy Combo Approved for MSI-H Colorectal Cancer